Skip to content
Bombay High Court

Glaxo Group Limited vs Shreya Life Sciences Pvt. Ltd And Others

COMMERCIAL MISCELLANEOUS PETITION 12 of 2026 · 28 October 2026

Judgments / Bombay High Court

Case details

Court
Bombay High Court
Case number
COMMERCIAL MISCELLANEOUS PETITION 12 of 2026
Date
28 October 2026
Judges
Somasekhar Sundaresan
Case type
Civil

Opening of the judgment

Context and Factual Background: 1. Glaxo Group Limited (“Glaxo”), the Petitioner, seeks cancellation of Trade Mark Registration No. 5001470 (“Impugned Registration”) for the mark ‘LEFOXIN BIOX’ in Class 5 (“Impugned Mark”). Shreya Life Sciences Pvt. Ltd. (“Shreya”), the Respondent No. 1, is the registered proprietor of the Impugned Mark. The captioned Rectification Petition is filed under Section 57 of the TM Act, 1999 (“TM Act”). 2. Glaxo is a company incorporated in England and Wales. It is part of the GSK group. It owns Trade Mark Registration No. 177607 for ‘LANOXIN’, also in Class 5 (“Glaxo Mark”), which has been in place since December 17, 1956, and has been kept renewed from time to t…

Read the full judgment

The complete text, citations, AI summary and original PDF are available inside Judisyn.